Transaction:

  • DCDC Kidney Care, which operates dialysis centers under the DCDC Kidney Care brand, has secured an investment of ₹150 crore from Singapore-based ABC Impact, the Asia-focused impact investor backed by Temasek.

About DCDC Kidney Care:

  • Founded in 2009, DCDC operates over 200 centers across India & is one of the foremost operators of dialysis clinics under public-private partnerships (PPP) & company-owned standalone clinics.
  • DCDC counts IFU, a Danish Government owned investment fund; and ADB (Asian Development Bank) among its existing shareholders.
  • Since 2021, it has significantly expanded, delivering nearly 100,000 dialysis sessions per month.

 

About ABC Impact:

  • ABC Impact is a Pan-Asia impact investment firm built on the UN Sustainable Development Goals focused on driving sustainable growth and delivering measurable social and environmental impact.
  • With over $ 900 Million in AUM across 2 funds, the firm employs a disciplined, thematic investment strategy to identify and scale high-potential businesses.

Rationale:

  • The investment from ABC Impact will support DCDC’s expansion plans, facilitating the rollout of over 150 new clinics across the country in the coming months.
  • With this investment, DCDC plans to expand our network of company-owned centers, ensuring last-mile connectivity and making high-quality dialysis care accessible closer to patients’ homes. DCDC also plans to address this challenge and extend their solutions to countries beyond India.
  • In December 2024, DCDC secured debt of Rs 82 crore from British International Investment (BII), the UK’s development finance institution and impact investor.
  • In 2014, DCDC raised $ 5 Mn in Series A Funding round from CDC Backed Pragati India. And in 2018, in Series B Funding round DCDC raised $ 10 Mn from Asian Development Bank.
  • On average, Patients in India must travel up to 50 km to access a dialysis center. This expansion will help address the growing need for accessible, affordable dialysis services for those with ESRD in line with the Ayushman Bharat Yojna.

 

Acknowledgements: 

RBI Bulletin (www.bulletin.rbi.org.in), SEBI (www.sebi.gov.in), NSE (www.nseindia.com), BSE (www.bseindia.com

Disclaimer:

This material has been prepared by the personnel in Vora Corporate Finance which is Investment Banking arm of Vora Management Consultancy Private Limited and looks after Mergers & Acquisitions (M&A), Private Equity (PE), Fund Raising, Debt syndication and Valuations and is based out of Ahmedabad, Gujarat, India. Any views or opinions expressed herein are solely that of individual authors and may differ from view of Vora Management Consultancy Private Limited. This material is proprietary to Vora Management Consultancy Private Limited and is for your personal use only. Any distribution, copy, reprints or forward to others is strictly prohibited.

This material captures the information based on information available in the public domain, public announcements and sources believed to be reliable. Analysis contained herein is based on publicly available information and appropriate assumptions. This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute strategic, investment, legal or tax advice. In no event Vora Management Consultancy Private Limited be liable for any use by any party or for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you for evaluating any transaction.